Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Teva
Deloitte
Daiichi Sankyo
Julphar
Covington
McKinsey
Merck
Accenture
Fuji

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021849

« Back to Dashboard

NDA 021849 describes ZEGERID, which is a drug marketed by Santarus Inc, Santarus, and Bayer Healthcare Llc, and is included in five NDAs. It is available from four suppliers. Additional details are available on the ZEGERID profile page.

The generic ingredient in ZEGERID is magnesium hydroxide; omeprazole; sodium bicarbonate. There are one hundred and thirty-seven drug master file entries for this compound. Additional details are available on the magnesium hydroxide; omeprazole; sodium bicarbonate profile page.
Summary for 021849
Tradename:ZEGERID
Applicant:Santarus Inc
Ingredient:omeprazole; sodium bicarbonate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021849
Suppliers and Packaging for NDA: 021849
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZEGERID omeprazole; sodium bicarbonate CAPSULE;ORAL 021849 NDA Physicians Total Care, Inc. 54868-5611 E 54868-5611-0
ZEGERID omeprazole; sodium bicarbonate CAPSULE;ORAL 021849 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-412 N 66993-412-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG;1.1GM
Approval Date:Feb 27, 2006TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength40MG;1.1GM
Approval Date:Feb 27, 2006TE:ABRLD:Yes

Expired US Patents for NDA 021849

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Chinese Patent Office
Moodys
Accenture
Covington
Queensland Health
Harvard Business School
Medtronic
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot